RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Journal of molecular cell biology
View this publicationJournal of molecular cell biology
View this publicationThe Journal of experimental medicine
View this publicationPublication categories: Top publication
The Journal of experimental medicine
View this publicationFrontiers in immunology
View this publicationPharmacology & therapeutics
View this publicationFrontiers in oncology
View this publication